End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.38 AUD | -3.80% | -3.80% | -20.00% |
05-07 | Argent BioPharma Reports CFO Appointment | MT |
05-07 | Argent BioPharma shares begin trading on OTCQB Venture Market | AN |
Sales 2022 | 4.73M 3.11M 249M | Sales 2023 | 3.39M 2.23M 178M | Capitalization | 16.75M 11.01M 883M |
---|---|---|---|---|---|
Net income 2022 | -20M -13.14M -1.05B | Net income 2023 | -20M -13.14M -1.05B | EV / Sales 2022 | 9.75 x |
Net Debt 2022 | 2.47M 1.62M 130M | Net Debt 2023 | 9.51M 6.25M 501M | EV / Sales 2023 | 7.75 x |
P/E ratio 2022 |
-2.02
x | P/E ratio 2023 |
-0.7
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 9.44% |
1 day | -3.80% | ||
1 week | -3.80% | ||
Current month | -7.32% | ||
1 month | -8.43% | ||
3 months | -2.56% | ||
6 months | -31.53% | ||
Current year | -20.00% |
Managers | Title | Age | Since |
---|---|---|---|
Roby Zomer
FOU | Founder | 44 | 20/10/05 |
Yifat Steuer
COO | Chief Operating Officer | 53 | 03/10/22 |
Nadya Lisovoder
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Roby Zomer
FOU | Founder | 44 | 20/10/05 |
Director/Board Member | - | 31/05/23 | |
Daniel Robinson
BRD | Director/Board Member | - | 11-30 |
Date | Price | Change | Volume |
---|---|---|---|
08/05/24 | 0.38 | -3.80% | 5,582 |
07/05/24 | 0.395 | +3.95% | 967 |
06/05/24 | 0.38 | 0.00% | 2,801 |
03/05/24 | 0.38 | -3.80% | 8,598 |
02/05/24 | 0.395 | 0.00% | 2,032 |
End-of-day quote Australian S.E., May 07, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.00% | 11.31M | |
+43.33% | 6.3B | |
-16.78% | 4.44B | |
-6.93% | 3.27B | |
+3.89% | 3.16B | |
-0.88% | 2.58B | |
+46.64% | 1.96B | |
-5.34% | 1.73B | |
+1.60% | 1.68B | |
-7.31% | 1.63B |
- Stock Market
- Equities
- RGT Stock